Management of patients with peripheral T-cell lymphoma

JO Armitage

doi:10.4081/hmr.v2i13.477

Abstracts

Vol. 2 No. 13 (2006)

https://doi.org/10.4081/hmr.v2i13.477

Management of patients with peripheral T-cell lymphoma

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

PDF

Published: 10 June 2009

232

Views

321

Downloads

Authors

JO Armitage

support@pagepress.org

The development of optimal therapy for any disease requires the ability to identify distinct clinical pathological entities likely to respond similarly to a particular treatment. For many years after the development of the first effective treatments for lymphoma, peripheral T-cell lymphomas continued to be lumped with the aggressive B-cell lymphomas in clinical trials.